Form 10-Q · Quarterly report

CME Group 10-Q, filed Oct 23, 2026

Filed
CIK
0001156375
Accession no.
0001156375-26-000068
AI-generated summary

Summary

CME Group reported third-quarter 2026 total revenues of $1.74 billion, up 13%, and net income of $1.04 billion, up 14%, as total contract volume rose 16% and aggregate average daily volume rose 16%. CME attributed higher trading activity to factors including persistent inflation that it said prompted the Federal Reserve's first interest-rate hike in over three years, AI-spending skepticism, and Middle East supply disruptions.

Key points

  • Q3 2026 total revenues rose 13% to $1.737 billion; net income rose 14% to $1.037 billion; diluted EPS rose 16% to $2.89.
  • Clearing and transaction fees rose 12% to $1.378 billion, while market data and information services revenue rose 20% to $243.1 million.
  • Total contract volume rose 16% to 1.8845 billion, and aggregate average daily volume rose 16% to 29.445 million contracts.
  • Average daily volume rose across interest rates (13%), equity indexes (23%), foreign exchange (19%), energy (16%), agricultural commodities (18%), and metals (13%); cryptocurrency volumes decreased, with Ether futures and options down 70%.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

From the filing

ITEM 2. MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS Financial Highlights The following summarizes significant changes in our financial performance for the periods presented. Quarter Ended September 30, Nine Months Ended September 30, (dollars in millions, except per share data) 2026 2025 Change 2026 2025 Change Total revenues $ 1,737.3 $ 1,537.6 13 % $ 5,323.6 $ 4,871.9 9 % Total expenses 595.9 565.0 5 1,765.4 1,662.0 6 Operating margin 65.7 % 63.3 % 66.8 % 65.9 % Non-operating income (expense) $ 213.4 $ 204.4 4 $ 635.2 $ 542.2 17 Effective tax rate 23.5 % 22.9 % 22.9 % 23.0 % Net income $ 1,036.9 $ 908.0 14 $ 3,233.0 $ 2,889.3 12 Diluted earnings per common share 2.89 2.49 16 8.96 7.92…

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow CME Group in Readster

Add CME Group to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.